Polymedics hosted an on-demand webinar on 14 January, titled “What can we expect of Novosorb BTM?”
The webinar was moderated by Dr. Clemens Schiestl, current President of the European Burns Association and a specialist paediatric reconstructive/plastic surgeon at the Zurich University Childrens’ Hospital.
The purpose of the webinar was to allow various “renowned users” of Novosorb BTM to share case studies and experiences.
Polymedic’s promotion of the webinar refers to Germany, Austria, Sweden, Holland and Italy.
https://polymedics.com/de/webinar-was-durfen-wir-von-novosorbbtm-erwarten/
https://www.euroburn.org/from-the-president/
PNV Media Thread, page-1083
-
- There are more pages in this discussion • 2,182 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.39 |
Change
0.000(0.00%) |
Mkt cap ! $1.650B | |||
| Open | High | Low | Value | Volume |
| $2.40 | $2.41 | $2.37 | $1.760M | 736.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 23241 | $2.38 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.39 | 381 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PNV (ASX) Chart |